This article is more than 5 years old. Information may no longer be current.

VIDEO: RNA blood test may aid in reducing diagnostic error for fibromyalgia

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

DESTIN, Fla. — The use of a blood sample to test if a patient’s gene expression pattern is consistent with fibromyalgia could assist health care providers in differentiating fibromyalgia from autoimmune conditions with similar symptoms, according to findings presented at the 2018 Congress of Clinical Rheumatology.

“We have developed a new diagnostic test for fibromyalgia syndrome that can be used by providers to distinguish fibromyalgia syndrome from other inflammatory like RA and lupus,” Chase Spurlock, PhD, CEO of IQuity, told Healio Rheumatology. “We find that using RNA data, which is a snapshot of real-time activity happening in the cells at any given time, coupled with our machine-learning algorithms produces a diagnostic effect that is more than 90% accurate.”

“We are excited about the opportunities for RNA diagnostics to make a difference in the lives of patients living with autoimmune and related conditions,” he said.